Trials / Completed
CompletedNCT04080596
DDI Study to Investigate the Impact of Itraconazole on the Pharmacokinetics of Dorzagliatin
A Single Dose, Open Label, Drug-drug Interaction Study to Investigate the Pharmacokinetics, Pharmadynamics and Safety of HMS5552 Administered Alone or in Combination With Itraconazole in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Hua Medicine Limited · Industry
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the impact of itraconzaole on the pharmacokinetics of Dorzagliatin.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dorzagliatin | GKA for T2DM currently under clinical development |
Timeline
- Start date
- 2017-10-13
- Primary completion
- 2017-12-05
- Completion
- 2017-12-05
- First posted
- 2019-09-06
- Last updated
- 2019-09-06
Locations
1 site across 1 country: China
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04080596. Inclusion in this directory is not an endorsement.